HBV基本核心啟動(dòng)子和前C區(qū)變異的深度測(cè)序分析
[Abstract]:Objective to investigate the characteristics of hepatitis B virus (HBV) (HBV) core promoter and precore region mutation in patients with hepatitis B virus (HBe Ag) positive chronic hepatitis B virus (CHB) by Ion Torrent PGM deep sequencing. Methods Serum samples of 25 patients with HBe Ag positive CHB were collected and HBV DNA was extracted. The HBV core promoter and precore region fragments were amplified by nested PCR method, and a deep sequencing library was constructed, which was based on Ion Torrent PGM platform. The mutation site and mutation rate were analyzed by bioinformatics, and the reference plasmids of the basic core promoter and precore promoter and wild type of HBV were constructed, which were used as quality control materials for deep sequencing. Results in 25 patients with HBe Ag positive CHB, 10 mutation sites with 20% prevalence rate were found in the basic core promoter and preC region of HBV. The prevalence rates of G1746A / A1752G / T / T1753C / G1764A / A1764A / A181764A / A181764A / A18176A / A1825C / A1846A / A1846A / G1896AG1899A G1746A and T1825C/A were 92% and 100%, respectively. The prevalence of G1746A and G1899A G1746A in 25 patients with HBe Ag positive CHB was 92% and 100%, respectively. The distribution of mutation locus in HBV B genotype and genotype C infection showed that A1762T and G1896A were mainly prevalent in patients with genotype B (63.6%vs 0.00, 蠂 ~ 2 12.374% P 0.00072.7 vs 28.6T, 蠂 ~ 2 + 4.812P 0.0472). A1762T and G1764A were mainly prevalent in C genotype carriers (27.3%vs 78.6p, 蠂 ~ 26.579P ~ (0.0172). Higher than genotype B, But there was no significant difference (25.7% 鹵28.4%vs 68.4% 鹵42.7%). Among 25 HBe Ag positive CHB patients, 32.0% had only A1762T/G1764A mutation 24.0%, only G1896A mutation 24.0% carried both A1762T/G1764A and G1896A mutations. Conclusion Deep-sequencing analysis can be used for quantitative detection of HBV core promoter and precore mutation, which provides a technical platform for clinical application of HBV mutation research.
【作者單位】: 江蘇大學(xué)醫(yī)學(xué)院免疫學(xué)系;北京大學(xué)人民醫(yī)院 北京大學(xué)肝病研究所 丙型肝炎及肝病免疫治療北京市重點(diǎn)實(shí)驗(yàn)室;中國(guó)科學(xué)院微生物研究所生物信息中心;
【基金】:國(guó)家自然科學(xué)基金(No.81273202;No.31400773) 國(guó)家重大科技專(zhuān)項(xiàng)(No.2012ZX10002011-006) 江蘇省臨床醫(yī)學(xué)科技專(zhuān)項(xiàng)(No.BL2013024)
【分類(lèi)號(hào)】:R373.21;R392
【參考文獻(xiàn)】
相關(guān)期刊論文 前1條
1 鄭彩霞;陳立;潘晨;;乙型肝炎病毒準(zhǔn)種的臨床意義[J];中華實(shí)驗(yàn)和臨床感染病雜志(電子版);2011年04期
【共引文獻(xiàn)】
相關(guān)期刊論文 前4條
1 閆琳琳;張恒輝;馬慧;劉翟;李偉;陳紅松;邵啟祥;;HBV基本核心啟動(dòng)子和前C區(qū)變異的深度測(cè)序分析[J];中華實(shí)驗(yàn)和臨床感染病雜志(電子版);2016年02期
2 趙洪奎;邊城;;阿德福韋酯治療慢性乙型肝炎過(guò)程中應(yīng)答不佳的相關(guān)因素分析[J];中國(guó)臨床新醫(yī)學(xué);2015年06期
3 趙婷婷;李小松;殷文偉;蔡雪飛;張文露;陳飛蘭;賴國(guó)旗;黃愛(ài)龍;;體內(nèi)轉(zhuǎn)導(dǎo)HBV cccDNA法建立HBV慢性感染的小鼠模型[J];中華肝臟病雜志;2014年04期
4 孫樹(shù)梅;周浩;周彬;;焦磷酸測(cè)序與PCR產(chǎn)物直接測(cè)序在乙型肝炎病毒耐藥基因檢測(cè)中的敏感性比較[J];中華醫(yī)院感染學(xué)雜志;2012年14期
【二級(jí)參考文獻(xiàn)】
相關(guān)期刊論文 前6條
1 羅志雄;劉映霞;彭忠田;李紅梅;;HBV準(zhǔn)種變異預(yù)測(cè)核苷(酸)類(lèi)似物治療HBeAg陽(yáng)性慢性乙型肝炎持續(xù)療效的初步研究[J];中華實(shí)驗(yàn)和臨床感染病雜志(電子版);2009年02期
2 溫志立;譚德明;彭仕芳;侯周華;成軍;;熔點(diǎn)曲線法研究乙型肝炎病毒準(zhǔn)種和臨床表現(xiàn)的關(guān)系[J];中華肝臟病雜志;2006年01期
3 成軍;董菁;劉妍;王琳;鐘彥偉;王剛;;準(zhǔn)種是乙型肝炎病毒存在的基本方式[J];世界華人消化雜志;2003年08期
4 蘭林,王宇明,黃燕萍;慢性乙型肝炎患者病毒準(zhǔn)種特性的初步研究[J];中華肝臟病雜志;2003年04期
5 劉映霞,胡國(guó)齡,譚德明;乙型肝炎病毒S區(qū)準(zhǔn)種與疾病活動(dòng)性的關(guān)系[J];中華傳染病雜志;2002年05期
6 董菁,成軍,王勤環(huán),王剛,施雙雙,劉妍,夏小兵,李莉,張國(guó)慶,斯崇文;乙型肝炎病毒C基因啟動(dòng)子區(qū)準(zhǔn)種與變異特點(diǎn)的研究[J];中華實(shí)驗(yàn)和臨床病毒學(xué)雜志;2002年03期
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 張忠東;成軍;鐘彥偉;楊倩;董菁;楊艷杰;張樹(shù)林;;羧肽酶N調(diào)節(jié)乙型肝炎病毒核心啟動(dòng)子表達(dá)活性的研究[J];世界華人消化雜志;2003年08期
2 侯婧逸;李華;康亞妮;孫潔林;;裂殖酵母核心啟動(dòng)子結(jié)構(gòu)的初步研究[J];核技術(shù);2013年03期
3 彭R,
本文編號(hào):2142947
本文鏈接:http://sikaile.net/xiyixuelunwen/2142947.html